|
|
||||||||
4
1 But Not
L
2 Integrin Dependent1



*
Dumont-University of California, Los Angeles Transplant Center, Department of Surgery, University of California, Los Angeles School of Medicine, Los Angeles, CA 90095; and
Institute of Medical Immunology, Charité, Humboldt-University, Berlin, Germany
The extravasation and sequestration of Ag-reactive T lymphocytes
into vascularized organ allografts depend on a cascade of complex
interactions among circulating lymphocytes, endothelial cells, and
extracellular matrix proteins. Ag-activated donor-specific CD4 T cells
are major initiators and effectors in the allograft rejection response.
Interfering with the intragraft homing of activated CD4 T cells may
represent a novel therapeutic approach in transplant recipients. We
have developed a FACS-based short-term homing assay that allows tracing
in vitro-generated Ag-reactive CD4 T cells after adoptive transfer in
test rat recipients. Allospecific cell lines were preincubated with
anti-
4
1 or
anti-
L
2 mAb, because of enhanced
expression of both integrin receptors after alloactivation. The
pretreated LewisBN lymphocytes were carboxyfluorescein
diacetate succinimidyl ester labeled and adoptively transferred into
Lewis rat recipients of Brown Norway kidney allografts. The injection
of equal numbers of PKH-26-labeled untreated cells allowed quantitative
comparison of both populations in the same animal. Ex vivo treatment
with anti-
4
1 mAb diminished
intragraft infiltration of adoptively transferred T cells by 85% in a
donor-specific fashion. In contrast, treatment with
anti-
L
2 mAb did not affect intragraft
cell sequestration. Hence, blocking
4
1
integrin interactions represents a novel strategy in preventing local
intragraft recruitment of Ag-reactive CD4 T cells in transplant
recipients.
This article has been cited by other articles:
![]() |
Z. Hmama, K. Sendide, A. Talal, R. Garcia, K. Dobos, and N. E. Reiner Quantitative analysis of phagolysosome fusion in intact cells: inhibition by mycobacterial lipoarabinomannan and rescue by an 1{alpha},25-dihydroxyvitamin D3-phosphoinositide 3-kinase pathway J. Cell Sci., April 15, 2004; 117(10): 2131 - 2140. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. Hammer, G. Schroder, K. Risch, A. Flugel, H.-D. Volk, M. Lehmann, and T. Ritter Antigen-Dependent Transgene Expression in Kidney Transplantation: A Novel Approach Using Gene-Engineered T Lymphocytes J. Am. Soc. Nephrol., February 1, 2002; 13(2): 511 - 518. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |